News/Events

New NHS service enables people to sign up to be contacted for COVID-19 vaccine studies
A new NHS service has been launched, helping people across the UK sign up for information on the new COVID-19 vaccine trials.Read more

Sponge on a string test to transform oesophageal cancer diagnosis
A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according new research. Read more

New funding boost to speed up diagnosis in oesophageal cancer
Cambridge will lead on improving early detection in oesophageal cancer as part of a Government backed projectRead more

National research platform launches new website
The address is the same, but the next time you visit the NIHR BioResource website, you’ll see it has a brand new look, ready for researchers and the public.Read more

TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19
As part of a new trial, a microbe will be used to treat severe COVID-19 in an experimental drug known as EDP1815. Read more

Phased re-start of non-COVID-19 research
In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more

Rapid COVID-19 test halves patient waiting times
A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

Cambridgeshire Trusts join COVID-19 vaccine trial
Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

POPStar study launches to investigate how pregnancy data can predict future health
A new study from the Departments of Obstetrics & Gynaecology and Paediatrics at the University of Cambridge is investigating how conditions in the womb can predict the future health of mothers and their children.Read more

Prestigious fellowship election for NIHR Cambridge BRC researchers
The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more

Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

Cambridge trial targets immune response to treat COVID-19 patients
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more

Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more

Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A UK-wide research collaboration through the National Institute for Health Research (NIHR) BioResource for Rare Diseases has combined whole genome sequencing (WGS) with a statistical program called BeviMed to predict the existence of disease-causing changes in the DNA of people with Primary Immunodeficiency (PID). Read more

NIHR Cambridge BRC and CRF begin working on new COVID-19 study
Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more

Fast-track HRA review of COVID-19 studies
The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more

First Addenbrooke’s Patient in National COVID-19 Trial
Today, Addenbrooke’s Hospital has enrolled our first patient into the national RECOVERY trial, led by Oxford researchers, which is hoping to identify potential treatments for COVID-19. The Randomised Evaluation of COVid-19 thERapY (RECOVERY) Read more

New National guidance for prioritising funding and support for COVID-19 research across the UK
Published by NIHR 26 March 2020:
Working with partners across the health and care system, NIHR is leading, enabling and delivering world-class COVID-19 research, a key element of the Government’s overall response to Read more

COVID-19 research studies at CUH
In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, whilst also supporting the care of patients with COVID-19 by Read more

Medovate working with CUH team to bring life-saving upper GI therapy device to market
Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device.
The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life-threatening Read more